B

AI Drug Preclinical Data Formatter

3.25

Derivation Chain

Step 1 Atomatrix–Daewon Pharmaceutical AI drug development collaboration
Step 2 Rapid growth of AI drug discovery Startups
Step 3 Automated format conversion for preclinical data regulatory submissions
Step 4 Preclinical data QC automation

Problem

When AI-driven biotech Startups submit preclinical data to MFDS (Korea FDA) or the U.S. FDA, converting data to SEND (Standard for Exchange of Nonclinical Data) format takes a single regulatory affairs (RA) specialist 2–4 weeks. About 80% of biotech Startups lack dedicated RA staff and rely on outsourcing at $15,000–$37,500 per submission.

Solution

(1) Upload preclinical results (Excel/CSV) for automatic conversion to SEND standard format (2) Automated compliance checks against FDA/MFDS submission requirements (3) Predictive flagging of likely review comments with pre-submission correction guidance.

Target: RA leads or CEOs at biotech/pharma Startups with 10–50 employees
Revenue Model: Per Transaction Billing — $750 per preclinical dataset conversion; Monthly Subscription at $1,500/month including 3 conversions
Ecosystem Role: Regulation
MVP Estimate: 2_weeks

NUMR-V Scores

N Novelty
4.0/5
U Urgency
4.0/5
M Market
3.0/5
R Realizability
2.0/5
V Validation
4.0/5
NUMR-V Scoring System
N Novelty1-5How uncommon the service is in market context.
U Urgency1-5How urgently users need this problem solved now.
M Market1-5Market size and growth potential from proxy indicators.
R Realizability1-5Buildability for a small team with realistic constraints.
V Validation1-5Validation signal quality from competition and demand data.
SaaS N=.15 U=.20 M=.15 R=.30 V=.20 Senior N=.25 U=.25 M=.05 R=.30 V=.15

Feasibility (69%)

Tech Complexity
29.3/40
Data Availability
20.0/25
MVP Timeline
20.0/20
API Bonus
0.0/15
Feasibility Breakdown
Tech Complexity/ 40Difficulty of core implementation stack.
Data Availability/ 25Practical availability and cost of required data.
MVP Timeline/ 20Expected time to ship a usable MVP.
API Bonus/ 15Bonus for viable public API leverage.

Market Validation (55/100)

Competition
8.0/20
Market Demand
6.2/20
Timing
14.0/20
Revenue Signals
12.0/15
Pick-Axe Fit
12.0/15
Solo Buildability
3.0/10
Validation Breakdown
Competition/ 20Signal quality from competitor landscape.
Market Demand/ 20Demand proxies from search and mention patterns.
Timing/ 20Fit with current shifts in tech, behavior, and regulation.
Revenue Signals/ 15Reference evidence for monetization viability.
Pick-Axe Fit/ 15How well the concept serves participants in a trend.
Solo Buildability/ 10Practicality for lean-team implementation.

Technical Requirements

Backend [medium] AI/ML [medium] Frontend [low]
Dashboard